| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | VNLG/124 | GDSC1000 | pan-cancer | AAC | 0.35 | 2e-28 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.33 | 2e-12 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.22 | 2e-10 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | BIX02189 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-08 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | 0.84 | 4e-08 |
| mRNA | AS605240 | GDSC1000 | pan-cancer | AAC | 0.18 | 4e-08 |
| mRNA | FR-180204 | GDSC1000 | pan-cancer | AAC | 0.19 | 5e-08 |
| mRNA | XL-184 | GDSC1000 | pan-cancer | AAC | 0.18 | 2e-07 |
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.16 | 2e-07 |